Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Open-market sale Horn Margaret A sold 1,267 shares at $19.04 ($24,127)
  2. 4 Open-market sale Chief Financial Officer sold 449 shares at $19.04 ($8,550)
  3. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  4. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 10,336 shares (option exercise)
  6. 4 Open-market buy Director bought 250,000 shares at $20.00 ($5,000,000)
  7. 4 Open-market buy Director bought 50,000 shares at $20.00 ($1,000,000)
  8. 4 Grant or award Director acquired 10,500 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale Wang Xiaolin sold 665 shares at $17.75 ($11,803)
  11. 4 Open-market sale Kelsey Stephen Michael sold 1,145 shares at $17.75 ($20,323)
  12. 4 Open-market sale Horn Margaret A sold 1,145 shares at $17.75 ($20,323)
  13. 4 Open-market sale Anders Jack sold 406 shares at $17.75 ($7,206)
  14. 4 Grant or award Director acquired 5,200 shares (grant or award)
  15. 4 Grant or award Director acquired 10,500 shares (grant or award)
  16. 4 Grant or award Director acquired 5,200 shares (grant or award)
  17. 4 Grant or award Director acquired 5,200 shares (grant or award)
  18. 4 Grant or award Director acquired 5,200 shares (grant or award)
  19. 4 Grant or award Director acquired 5,200 shares (grant or award)
  20. 4 Grant or award Director acquired 5,200 shares (grant or award)

Page 14 of 21 · 414 filings